INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,806 | +11.2% | 152 | +43.4% | 0.00% | 0.0% |
| Q2 2023 | $4,323 | +0.9% | 106 | -7.8% | 0.00% | 0.0% |
| Q1 2023 | $4,286 | -30.2% | 115 | -34.7% | 0.00% | 0.0% |
| Q4 2022 | $6,141 | -52.8% | 176 | -22.5% | 0.00% | -66.7% |
| Q3 2022 | $13,000 | +8.3% | 227 | -5.4% | 0.00% | +50.0% |
| Q2 2022 | $12,000 | -33.3% | 240 | -4.4% | 0.00% | -33.3% |
| Q1 2022 | $18,000 | -14.3% | 251 | +38.7% | 0.00% | -25.0% |
| Q4 2021 | $21,000 | -40.0% | 181 | -30.4% | 0.00% | -42.9% |
| Q3 2021 | $35,000 | +25.0% | 260 | +47.7% | 0.01% | +16.7% |
| Q2 2021 | $28,000 | +100.0% | 176 | +2.3% | 0.01% | +100.0% |
| Q1 2021 | $14,000 | -22.2% | 172 | -49.4% | 0.00% | +50.0% |
| Q4 2020 | $18,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |